Medical/Pharmaceuticals
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Chile
* Marks vaccine's first approval in South America, following Mexico, Pakistan, China and Hungary * Safe, stable storage and transportation between 2°C and 8°C, accessible by under-developed regions * 95.47% effective overall in preventing severe COVID-19 diseases 14 days after vaccination TI...
Lunit will participate in a Groundbreaking Prospective Study to Validate AI Performance
* A research team at the Karolinska Institutet in Sweden will assess the performance of AI startup Lunit's breast cancer AI software as an independent mammography reader in screening * The prospective study marks first of its kind, aiming to screen 55,000 women with mammography at Capio Sankt...
SenseTime Receives CE Mark for its AI Medical Solution SenseCare- Chest DR Pro Diagnostic Software
HONG KONG, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickl...
SenseTime Receives CE Mark for its AI Medical Solution SenseCare- Chest DR Pro Diagnostic Software
SINGAPORE, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickl...
SenseTime Receives CE Mark for its AI Medical Solution SenseCare-Chest DR Pro Diagnostic Software
KUALA LUMPUR, Malaysia, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solut...
SenseTime Receives CE Mark for its AI Medical Solution SenseCare-Chest DR Pro Diagnostic Software
BANGKOK, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickly ...
EyeYon Medical Announces Innovative Medical Device Designation Granted For EndoArt® In China
TEL-AVIV, Israel, April 8, 2021 /PRNewswire/ -- EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announces today that EndoArt® was granted the Innovative Device Status byChina's Center for Medical Device Evaluation, the ar...
Inmagene R&D Team expands with two new senior members joining the Company
SAN DIEGO and SHANGHAI and HANGZHOU, China, April 7, 2021 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") today announced that Dr.Anbo Xiang and Dr.Qian Xu joined the company. As CMO (China) and Senior VP, Operations, Dr. Xiang will be responsible for clinical development, operations, an...
WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA
WUXI, China, April 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that it has successfully completed both a Pre-License Inspection (PLI) and a routine GMP inspection by the U.S. FDA (FDA). T...
EDDA Technology Announces US$150 Million Financing Round, led by Softbank Vision Fund 2, with OrbiMed Participation, to Advance Intelligent Robotic Solutions for Precision Surgery
SHANGHAI and SUZHOU, China, April 7, 2021 /PRNewswire/ -- EDDA Healthcare and Technology Holding Ltd. and its subsidiaries EDDA Technology (Shanghai) Ltd., EDDA Technology Medical Solutions (Suzhou) Ltd., and EDDA Technology, Inc ( Princeton, NJ, USA), (hereafter jointly referred to as EDDA Techno...
Shanghai Genechem Co., Ltd. (Genechem) Announces Global Collaboration on Bispecific Antibodies
SHANGHAI, April 6,, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, today announced the execution of a global collaboration with I-Mab (Nasdaq: IMAB), a Nasdaq-listed global bioph...
Gan & Lee receives EMA orphan drug designation for Phase I drug candidate GLR2007 for the treatment of glioma
BEIJING, and BRIDGEWATER, N.J., April 6, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), a global biopharmaceutical company, today announced that the European Medicine Agency (EMA) Committee for Orphan Medicinal Products ...
Smart Glove Acclaimed by Frost & Sullivan for Introducing Several First-of-their-kind Medical Gloves to the Market
Smart Glove is a global leading supplier of nitrile, latex, vinyl, and other synthetic gloves for industries ranging from healthcare to food and beverage KUALA LUMPUR, Malaysia, April 6, 2021 /PRNewswire/ -- Based on its recent analysis of the global medical gloves market, Frost & Sullivan recogn...
How to Power Your Hospital with Artificial Intelligence in Medical Imaging
Frost & Sullivan's white paper highlights the process of creating an AI strategy for your imaging department SANTA CLARA, Calif., April 6, 2021 /PRNewswire/ -- The medical imaging industry is in the midst of large-scale transformation, largely driven by the advancements in technologies such as a...
Review of Myopia Management and Plano Announce New Content Partnership
SINGAPORE, April 6, 2021 /PRNewswire/ -- Review of Myopia Management
Antengene Announces NMPA Approval of IND Application for ATG-019 in Patients with Advanced Solid Tumors or Non-Hodgkin's Lymphoma
SHANGHAI and HONG KONG, April 6, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...
Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover
* Crossover allows participants to continue in trials and remain blinded * Ensures that all trial participants receive active vaccine * South Africa and UK crossover arms initiated; US/Mexico PREVENT-19 crossover planned GAITHERSBURG, Md., April 6, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq:...
AI-Based Imaging Analysis Tools and Cloud-Based Deployments to Bolster the Global Digital Pathology Market
SANTA CLARA, Calif., April 5, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, AI-Based Image Analysis Tools and Cloud-Based Deployment to Expand the Global Digital Pathology Market, finds that this market is estimated to hit $825.9 million by 2025 from $513.3 million in 2019 at a compoun...
Pfizer collaborates with DoctorOnCall to improve health literacy and patient care in Malaysia
KUALA LUMPUR, Malaysia, April 5, 2021 /PRNewswire/ -- Pfizer today announced its collaboration with DoctorOnCall to launch a digital therapeutics platform that focuses on three key therapeutic areas namely smoking cessation, vaccination, and heart health. Catering to an increasingly tech-savvy an...
Ascentage Pharma Appoints Renowned Oncologist Dr. David Sidransky, MD, to its Board as an Independent Non-Executive Director
SUZHOU, China and ROCKVILLE, Md., April 2, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its appointment of Dr.David ...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 272 media titles]
2024-04-24 17:09